Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosis

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Hartung, Viktor ^a   Prell, Tino ^a   Gaser, Christian ^a   Turner, Martin R ^b   Tietz, Florian ^a   Ilse, Benjamin ^c   Bokemeyer, Martin ^a   Witte, Otto W ^a   Grosskreutz, Julian ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMAGING AND DISPLAY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL CORTEX; PYRAMIDAL TRACT; VOXEL BASED INTENSITOMETRY; WHITE MATTER INJURY; BRAIN; MIDDLE AGED; PATHOLOGY; PROCEDURES; WHITE MATTER;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; CEREBRUM; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; WHITE MATTER;

EID: 84940245748     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104894     Document Type: Article

References (37)

1. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2): 257-268.
2. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2): 245-256.
3. Turner MR, Kiernan MC, Leigh PN, Talbot K (2009) Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 8(1): 94-109.
4. Swash M (2012) Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry 83(6): 659-662.
5. Kassubek J, Bretschneider V, Sperfeld AD (2005) Corticospinal tract MRI hyperintensity in X-linked Charcot-Marie-Tooth Disease. J Clin Neurosci 12(5): 588-589. (Pubitemid 41044208)
6. Keil C, Prell T, Peschel T, Hartung V, Dengler R, et al. (2012) Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci 13: 141.
7. Rose S, Pannek K, Bell C, Baumann F, Hutchinson N, et al. (2012) Direct evidence of intra- and interhemispheric corticomotor network degeneration in amyotrophic lateral sclerosis: an automated MRI structural connectivity study. Neuroimage 59(3): 2661-2669.
8. Kassubek J, Unrath A, Huppertz HJ, Lule D, Ethofer T, et al. (2005) Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph Lateral Scler Other Motor Neuron Disord 6(4): 213-220.
9. Mezzapesa DM, Ceccarelli A, Dicuonzo F, Carella A, De Caro MF, et al. (2007) Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 28(2): 255-259. (Pubitemid 46281040)
10. Chang JL, Lomen-Hoerth C, Murphy J, Henry RG, Kramer JH, et al. (2005) A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology 65(1): 75-80. (Pubitemid 40967780)
11. Agosta F, Pagani E, Rocca MA, Caputo D, Perini M, et al. (2007) Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp 28(12): 1430-1438. (Pubitemid 350237659)
12. Grosskreutz J, Kaufmann J, Fraedrich J, Dengler R, Heinze HJ, et al. (2006) Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis. BMC Neurol 6(1): 17.
13. Ellis CM, Suckling J, Amaro E Jr, Bullmore ET, Simmons A, et al. (2001) Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS. Neurology 57(9): 1571-1578. (Pubitemid 33055472)
14. Agosta F, Gorno-Tempini ML, Pagani E, Sala S, Caputo D, et al. (2009) Longitudinal assessment of grey matter contraction in amyotrophic lateral sclerosis: A tensor based morphometry study. Amyotroph Lateral Scler 10(3): 168-174.
15. Bede P, Bokde A, Elamin M, Byrne S, McLaughlin RL, et al. (2012) Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry 84(7): 766-73.
16. Chen Z, Ma L (2010) Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: A voxel-wise meta-analysis of voxel based morphometry studies. Amyotroph Lateral Scler 11(6): 549-554.
17. Ashburner J, Friston KJ (2000) Voxel-based morphometry - the methods. Neuroimage 11(6 Pt 1): 805-821. (Pubitemid 30437668)
18. Ashburner J, Friston K (1997) Multimodal image coregistration and partitioning - a unified framework. Neuroimage 6(3): 209-217. (Pubitemid 27488452)
19. Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44(1): 83-98.
20. Turner MR, Agosta F, Bede P, Govind V, Lule D, et al. (2012) Neuroimaging in amyotrophic lateral sclerosis. Biomark Med 6(3): 319-337.
21. Menke RA, Abraham I, Thiel CS, Filippini N, Knight S, et al. (2012) Fractional anisotropy in the posterior limb of the internal capsule and prognosis in amyotrophic lateral sclerosis. Arch Neurol 69(11): 1493-1499.
22. Canu E, Agosta F, Riva N, Sala S, Prelle A, et al. (2011) The topography of brain microstructural damage in amyotrophic lateral sclerosis assessed using diffusion tensor MR imaging. AJNR Am J Neuroradiol 32(7): 1307-1314.
23. Ciccarelli O, Behrens TE, Johansen-Berg H, Talbot K, Orrell RW, et al. (2009) Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics. Hum Brain Mapp 30(2): 615-624.
24. Smith MC (1960) Nerve Fibre Degeneration in the Brain in Amyotrophic Lateral Sclerosis. J Neurol Neurosurg Psychiatry; 23: 269-282.
25. Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, et al. (2010) Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 75(18): 1645-1652.
26. Kolind S, Sharma R, Knight S, Johansen-Berg H, Talbot K, et al. (2013) Myelin imaging in amyotrophic and primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 14(7-8): 562-73.
27. Douaud G, Filippini N, Knight S, Talbot K, Turner MR (2011) Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis. Brain 134(12): 3470-9.
28. Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, et al. (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83(1): 102-108.
29. Chio A, Calvo A, Moglia C, Mazzini L, Mora G (2011) Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 82(7): 740-746.
30. Cistaro A, Valentini MC, Chio A, Nobili F, Calvo A, et al. (2011) Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging 39(2): 251-9.
31. Ding XQ, Kollewe K, Blum K, Korner S, Kehbel S, et al. (2011) Value of quantitative analysis of routine clinical MRI sequences in ALS. Amyotroph Lateral Scler 12(6): 406-413.
32. Hall ED, Oostveen JA, Gurney ME (1998) Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23(3): 249-256. (Pubitemid 28259722)
33. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, et al. (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312(5778): 1389-1392. (Pubitemid 43839552)
34. Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, et al. (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15(3): 601-609. (Pubitemid 38429975)
35. Evans MC, Couch Y, Sibson N, Turner MR (2013) Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Mol Cell Neurosci 53: 34-41.
36. Turner MR, Grosskreutz J, Kassubek J, Abrahams S, Agosta F, et al. (2011) Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol 10(5): 400-403.
37. Miller KL, Stagg CJ, Douaud G, Jbabdi S, Smith SM, et al. (2011) Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner. Neuroimage 57(1): 167-181.